4833M 15/500 (Actoplus met 500 mg / 15 mg)

Generic Name: metformin/pioglitazone

Pill imprint 4833M 15/500 has been identified as Actoplus met 500 mg / 15 mg.

ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 500 mg / 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 4833M 15/500 (Actoplus met 500 mg / 15 mg)

Actoplus met 500 mg / 15 mg 4833M 15/500 Front
Actoplus met 500 mg / 15 mg 4833M 15/500 Back
Actoplus met 500 mg / 15 mg 4833M 15/500
Actoplus met
Generic Name:
metformin/pioglitazone
Imprint:
4833M
15/500
Strength:
500 mg / 15 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Takeda Pharmaceuticals America, Inc.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)